Muang Thai Life Issuer Summary

Report date: 2026-05-13
Issuer: Muang Thai Life Assurance Public Company Limited
Sector: Thailand life insurance
Primary credit focus: issuer credit, insurance financial strength, ranking differential of the USD Tier 2 subordinated notes, and the resilience of insurance liabilities, investment assets and RBC

1. Business Snapshot and Recent Developments

Muang Thai Life Assurance Public Company Limited (“Muang Thai Life” or “MTL”) is a major life insurer based in Thailand. The starting point for credit analysis is to view the company not as a bank, securities firm or general corporate, but as a life insurance issuer with long-term liabilities to policyholders and a large investment asset base on the other side of the balance sheet. Credit quality cannot be assessed solely by premium growth. It is necessary to look simultaneously at the quality of insurance liabilities, product guarantees, surrender and persistency, medical claims, ALM, market and credit risk in investment assets, regulatory capital, and the capital recognition of subordinated debt.

MTL was established on 6 April 1951 and converted into a public company on 1 October 2012. As of end-2024, its direct shareholders were Muang Thai Group Holding Company Limited with 75.00003%, Ageas Insurance International N.V. with 24.99990%, and others with 0.00007%. The shareholders of Muang Thai Group Holding include Kasikornbank PCL (KBANK) with 51.00000%, Lamsam Group and individual shareholders with 41.16675%, and Ageas Insurance International N.V. with 7.83325%. MTL is therefore formally a subsidiary of Muang Thai Group Holding, but it is more natural to view it economically as an insurer influenced by KBANK, the Lamsam family and related parties, and Ageas.

This shareholder structure is a credit support factor, but it is not an explicit guarantee. KBANK is a major Thai bank and entered into a 10-year bancassurance agreement with MTL on 2 July 2021. The agreement provides for the exclusive offering and sale of MTL’s life insurance products through the distribution channels of KBANK, five of its subsidiaries, and any wholly owned subsidiaries that may be established in the future. Ageas, as an international insurance group, complements MTL’s insurance product, risk management, capital management and regional expansion expertise. These factors support distribution, expertise, governance and brand value, but they do not mean that the parent company or the bank guarantees principal and interest payments on bonds or subordinated notes. This distinction is made explicit in the structural analysis below.

In terms of business performance in 2024, MTL maintained a leading position in the Thai life insurance market. According to the company’s 2024 annual report, new business premium (NBP) for the year was THB26,958 million, ranking second in the industry, with a 14.6% share and 13.6% year-on-year growth. The company attributed this to stronger sales of protection products, whole-life insurance, health and critical illness products, and long-term savings products. Total premium for the year was THB71,817 million, up 1.2% year on year, with an 11.0% share. Renewal year premium (RYP) was THB44,859 million, down 5.1% year on year. The company explained that the decline in renewal premium included the effects of maturities and paid-up policies. In credit analysis of an insurer, it is important to look not only at NBP growth but also at the stability of renewal premium from the in-force book, making this combination important.

Among official disclosures after the start of 2025, the latest major financial update is the IR Fact Sheet Vol.98 (Q3 2025), released on 25 November 2025. According to the fact sheet, for January–September 2025, MTL’s NBP was THB18,755.19 million, with a 13.45% share and third place in the industry; RYP was THB32,274.48 million, with a 9.33% share and fourth place; and total premium was THB51,029.67 million, with a 10.51% share and fourth place. Total industry premium for the same period was THB482,351.28 million, up 4.30% year on year. MTL’s total premium share declined slightly from 11.0% for full-year 2024 to 10.51% for January–September 2025, but the company remains one of the major market participants.

Financially, total assets in the audited financial statements at end-2024 were approximately THB643.1 billion, investments in securities were approximately THB569.7 billion, life insurance reserves and insurance premium reserves were approximately THB524.1 billion, and net profit on an equity-method basis was THB5.6 billion. The Q3 2025 fact sheet shows total assets of THB704.2 billion and a capital adequacy ratio (CAR) of 499%. However, the fact sheet notes that the asset data are based on new accounting standards, so the figures should not be compared too mechanically with the 2024 audited financial statement numbers as a simple time series. In credit analysis, the 2024 audited figures should be used to confirm the financial structure, while the Q3 2025 fact sheet should be used to supplement the latest asset scale, capital buffer and premium share.

On ratings, Fitch Ratings affirmed MTL’s Insurer Financial Strength (IFS) rating at A-, Long-Term Issuer Default Rating (IDR) at BBB+, National IFS rating at AAA(tha), and Stable Outlook on 20 February 2025. Fitch recognised the company’s “Favourable” company profile and “Strong” capital position, while citing the high risk-asset exposure of its investment portfolio as a constraint. MTL’s USD Tier 2 subordinated notes are rated BBB by Fitch, with a clear notching differential from the insurance financial strength rating and issuer rating. The company fact sheet also shows an S&P Global Ratings rating of BBB+ / Stable as of 29 October 2024, but the full text of S&P’s detailed 2024 update has not been obtained for this report.

In summary, the current credit issues are as follows: MTL is an investment-grade insurer with a leading franchise in the Thai life insurance market and a high regulatory capital ratio, but it is also an issuer with long-term insurance liabilities and a large investment asset base, subject to constraints from investment risk, interest rates, medical claims, product mix, renewal premium and the ranking of subordinated debt. The credit view is not determined by premium growth alone or by the headline CAR alone. The resilience of an insurer should be assessed by looking together at the quality of products and liabilities, loss-absorption capacity of investment assets, ALM, the composition of capital, and the effectiveness of shareholder and distribution-channel support.

2. Industry Position and Franchise Strength

The Thai life insurance market includes savings, protection, health, retirement-preparation and investment-linked products, with competition across bancassurance, agency, broker and digital channels. Credit analysis should focus not only on market growth, but also on which products are sold through which channels, and with what profitability, capital consumption and insurance liability characteristics.

The core of MTL’s franchise is its leading position and distribution network in the Thai life insurance market. For full-year 2024, NBP ranked second in the industry with a 14.6% share, while total premium share was 11.0%. For January–September 2025, MTL also maintained third place in NBP and fourth place in total premium. The company combines agents, nationwide branches, banks, online and app channels, and various partnerships. In particular, the bancassurance agreement with KBANK provides access to the bank’s customer base. However, bancassurance is not a debt guarantee. It should be viewed as a business support factor driven by sales volume, fees, product mix and the bank’s own distribution policy.

On products, MTL offers whole life, endowment and savings products, term life, loan-related insurance, group insurance, retirement-preparation products, unit-linked products, universal life, takaful, accident insurance, and health and critical illness riders. The company also explained that 2024 NBP growth was driven by stronger sales of protection products, whole life, health and critical illness, and long-term savings products. However, product breadth is not simply positive. Health and critical illness products carry medical inflation and claims risk; savings-type products carry guaranteed-rate and ALM risk; and unit-linked products carry sales-quality, surrender and complaint risk in market downturns. The key question is not whether a product sells, but whether the company can sustainably sell products whose capital consumption is commensurate with their risk.

In evaluating MTL’s market position, the decline in total premium share from 11.0% in 2024 to 10.51% in Q3 2025 also needs to be considered. This decline itself is not large enough to impair the company’s major-market status. Rankings in life insurance markets can shift because of single-year product campaigns, bancassurance sales plans, interest-rate conditions, peer product launches, and waves of maturities or paid-up policies. However, if the decline in renewal premium and the slight decline in total premium share continue, it will be necessary to examine whether there has been any change in the persistency of the in-force book, product appeal, or the selling power of agents and bancassurance.

MTL’s competitive characteristics lie in the combination of its standalone insurer brand, KBANK channel, Ageas insurance expertise, digital touchpoints, and shift toward health and protection products. Multiple support factors stabilise the business base, but bondholders should distinguish between MTL as the repayment entity and the ordinary-course business support provided by KBANK, Ageas and Muang Thai Group.

3. Segment Assessment

For MTL, segment analysis cannot be limited to a simple listing of revenue and operating profit by business line. In a life insurer, product type, distribution channel, the nature of insurance liabilities, investment assets, reinsurance and capital consumption jointly determine credit quality. Public disclosures provide limited detail on profitability by product, claims ratios, surrender rates, persistency rates and reinsurance programmes, so this report organises the analysis based on the observable outline of products, distribution and regional investments.

There are five main business axes. Long-term savings, endowment and whole-life products can generate premium scale and long-duration contracts, but they are sensitive to guaranteed rates, surrender values, investment yields and interest-rate changes. Protection, health and critical illness products can enhance the core value of insurance and potentially reduce reliance on interest-rate guarantees, but medical inflation, treatment costs, utilisation frequency, reinsurance and scope for repricing are important. Unit-linked and universal life products can shift part of the investment risk to policyholders, but carry sales-quality, surrender and complaint risk during market downturns. Group and loan-related insurance may fit well with the KBANK channel, but are affected by the credit cycle and customer protection regulation. Overseas affiliates and regional expansion provide growth options, but it has not been confirmed whether they are currently large enough to determine MTL’s standalone credit quality; they are therefore treated as sources of complexity through capital deployment, local regulation, foreign exchange and start-up earnings.

The central issue across products and business axes is that MTL is not merely a company that collects a large amount of premium, but a company whose credit profile depends on which liabilities are supported by which assets. At end-2024, investments in securities were approximately THB569.7 billion and life insurance reserves and insurance premium reserves were approximately THB524.1 billion. The business credit risk is therefore driven not only by premium acquisition capacity, but also by ALM, investment risk, and the guarantees, maturity profile and surrender characteristics of insurance liabilities. Because product-level margins and claims ratios have not been obtained, the expansion of protection and health products should not be characterised definitively as a profitability improvement.

4. Financial Profile and Analysis

MTL’s financial profile shows reasonable scale for an insurer, a high regulatory capital ratio and stable earnings, while disclosure granularity on investment assets and insurance liabilities remains constrained. Credit analysis should read total premium, net profit and total assets together with investments in securities, insurance contract reserves, cash and short-term investments, subordinated debt, CAR/RBC and investment risk.

In the 2024 income statement, gross premiums written were THB71,790 million, net premiums earned were THB67,288 million, net investment income was THB21,255 million, gain on investments was THB2,444 million, and total revenues were THB91,848 million. In terms of profit, profit before income tax on an equity-method basis was THB6,861 million, and profit attributable to ordinary shareholders was THB5,606 million. The corresponding 2023 profit attributable was THB5,734 million, so 2024 was a slight decline in earnings. As a life insurer, the company has a large premium base, and investment income is also an important pillar of earnings.

This earnings level is credit-positive, but it cannot be described as an especially strong earnings profile. Taking end-2024 total assets at approximately THB643.1 billion, net profit of THB5.6 billion on an equity-method basis represents a return on assets of less than 1%. For insurers, asset size is large and profitability does not have the same meaning as for banks or general corporates, but the earnings buffer can become thin if investment valuation losses, higher claims, reserve increases or higher distribution commissions occur. MTL’s credit quality is therefore supported less by rapidly rising profits and more by the combination of a leading franchise, premium scale, investment income and a regulatory capital buffer.

On the balance sheet, investments in securities account for most of total assets. End-2024 investments in securities were approximately THB569.7 billion, equivalent to around 89% of total assets of approximately THB643.1 billion. Notes to the annual report show FVTOCI equity securities of THB76.1 billion, FVTOCI debt securities of THB10.2 billion, and amortised-cost debt securities, net, of THB472.1 billion. KBANK’s 4Q 2024 investor materials show MTL’s AUM at THB604.9 billion, with fixed-income assets accounting for approximately 82%. The breakdown was 54% government and state-enterprise bonds, 28% debentures / deposits / notes, 8% stocks, 5% unit trusts, 4% loans and others, and 1% investment property. Although the portfolio is fixed-income oriented, equities, unit trusts, debentures / deposits / notes and interest-rate sensitivity affect capital and earnings, so Fitch’s identification of high risk-asset exposure as a constraint is consistent with this profile.

Some granularity on credit risk can be confirmed. At end-2024, amortised-cost debt securities consisted of THB468.7 billion in Stage 1, THB4.8 billion in Stage 2, and THB15.6 million in Stage 3 before allowance, with zero after allowance. By rating, amortised-cost bonds consisted of THB251.0 billion of credit-risk-free assets, THB196.0 billion rated above BBB, THB26.4 billion rated BBB and below, and THB15.6 million non-rated. This indicates that the majority of the bond portfolio is high-rated or credit-risk-free, but the overall picture by equities of THB76.1 billion, ratings, currency and duration is still insufficient.

On the insurance liability side, life insurance reserves and insurance premium reserves were THB524,082 million at end-2024, and long-term technical reserves were THB519,470 million. KBANK materials show that the increase (decrease) in long-term technical reserves from the previous period in 2024 was negative THB3.0 billion, while net benefit payments and insurance claims were THB71.5 billion, a large increase from THB53.2 billion in 2023. Claims ratios by product and claims ratios for health insurance cannot be obtained from the annual report text alone, so the profitability of health and protection products is unconfirmed. For bond investors, guaranteed rates, liability duration, surrender characteristics, reinsurance and matching with asset duration should be examined in the next update.

In terms of liquidity, cash and cash equivalents at end-2024 were THB10,631 million, up from THB8,056 million at end-2023. Insurer liquidity needs to be assessed based on claims payments, surrenders, maturities, saleability of investment assets and maintenance of regulatory capital. The investment asset base is large, and the portion centred on government and state-enterprise bonds can potentially serve as a liquidity source. However, in a stress scenario, market price declines and weaker liquidity can occur simultaneously.

On capital, the company fact sheet shows CAR of 353% in 2023, 448% in 2024 and 499% in Q3 2025. This is far above the OIC minimum of 140%, and the regulatory capital buffer is a clear credit support factor. In its February 2025 release, Fitch also stated that the RBC ratio was 381% at end-3Q24, compared with 353% in 2023 and 332% in 2022, and that the Fitch Prism Global Model score was Strong. The CAR shown in the company fact sheet and the RBC quoted by Fitch may differ by timing and calculation basis, but both point in the same direction: the ratios are well above the regulatory minimum.

However, a high CAR should not be read unconditionally as sufficient capital. MTL has USD subordinated notes intended to qualify as Tier 2 capital, with a book value of THB10,224 million at end-2024. This is equivalent to approximately 1.6% of end-2024 total assets, approximately 2.0% of life insurance reserves and insurance premium reserves, and approximately 11% of end-2024 equity of THB93.2 billion as shown in KBANK materials. Tier 2 capital strengthens the issuer’s capital base, but for subordinated note investors it means capital features, redemption restrictions and regulatory approval risk. In addition, if investment risk assets, product guarantees or insurance liability valuations deteriorate, the apparent CAR headroom could shrink.

On dividends, the shareholders’ meeting on 22 April 2024 approved dividends totalling THB1,135 million, which were paid in May 2024. This was approximately 20% of 2024 net profit of THB5,606 million and does not appear to be an excessively high payout ratio, but the balance between retained earnings and the CAR level should continue to be monitored.

5. Structural Considerations for Bondholders

For MTL bondholders, the first structural issue to confirm is the ranking of insurance company liabilities. In a life insurer, policy reserves and claims payments to policyholders are the core business liabilities, and the regulator places priority on policyholder protection and capital maintenance. Bond investors, especially subordinated note investors, may be constrained by insurance liabilities, regulatory capital, supervisory decisions and the terms of capital securities even when the issuer is profitable.

The important external market debt of MTL is its USD Tier 2 subordinated notes. According to the notes to the annual report, the company has subordinated instruments intended to qualify as Tier 2 capital, with a coupon of 3.552%, maturity in 2037 and a book value of THB10,224 million at end-2024. Issuance materials from 2021 indicated a principal amount of USD400 million, part of which was repaid in 2023, and Fitch’s 2025 release refers to USD300 million outstanding. Fitch rates the Tier 2 subordinated notes BBB, below MTL’s IFS of A- and IDR of BBB+.

This rating differential is fundamental for bond investors. The IFS rating indicates the ability to meet obligations to policyholders, while the IDR looks at the issuer’s general default risk. By contrast, Tier 2 subordinated notes rank below policyholder liabilities and senior debt, and have loss-absorption features as regulatory capital. Therefore, even if the issuer’s insurance financial strength is investment grade, recovery, interest-payment and redemption risks for Tier 2 need to be assessed separately. The points confirmed in this report are that the instruments are subordinated instruments intended to qualify as Tier 2, have a coupon of 3.552%, mature in 2037, had a book value of THB10,224 million at end-2024, and are described by Fitch as USD300 million outstanding. Coupon deferral, write-down, conversion, regulatory call, non-viability, and OIC approval conditions for redemption are items to confirm before any individual investment as regulatory-eligible Tier 2 features; they have not been confirmed as actual terms of this bond.

The shareholder structure also provides both support and constraints for bondholders. KBANK is a 51% shareholder of Muang Thai Group Holding and provides a distribution channel through the bancassurance agreement with MTL. Ageas is involved in MTL directly and indirectly, providing insurance expertise and international know-how. Fitch also cites consistent operational support from KBANK and Ageas as supporting the company profile. This is positive for distribution, product development, risk management, brand value and capital-market access.

However, this support is not a legal guarantee. This report has not confirmed any explicit guarantee by KBANK, Ageas or Muang Thai Group Holding for MTL’s bonds or subordinated notes. Past public commentary by S&P also viewed MTL as strategically important to KBANK, while treating MTL’s credit profile as somewhat separate from KBANK’s because of regulatory separation between banking and insurance and the presence of Ageas as a third-party shareholder. Therefore, shareholder support should not be overestimated as a credit enhancement. The support is ordinary-course support for distribution, operations and expertise, and is different from a guarantee of debt repayment under stress.

The ranking among policyholders, senior creditors, subordinated creditors and shareholders must also be clearly distinguished. When an insurer comes under stress, policyholder protection and regulatory capital maintenance are the first priorities. Because subordinated debt has capital features, interest suspension or redemption deferral may be possible under the relevant framework. Common shareholders rank further below, but shareholder distributions in normal times may constrain capital accumulation. Bondholders need to check not only the issuer-level rating but also which security occupies which ranking position and which regulatory constraints apply.

6. Capital Structure, Liquidity and Funding

MTL’s capital structure and liquidity show a relatively strong regulatory capital buffer for an insurer. The company fact sheet shows CAR of 353% in 2023, 448% in 2024 and 499% in Q3 2025, well above the OIC minimum of 140%. Fitch also cites an end-3Q24 RBC ratio of 381% and a Prism Global Model score of Strong, using the capital position as a rating support factor. However, this assessment relies significantly on the regulatory capital ratio and Fitch’s analysis; it is not an internally derived economic-value assessment that fully incorporates investment asset duration, foreign currency exposure, detailed risk assets and insurance liability sensitivities.

At the same time, the quality of capital should be assessed together with Tier 2 subordinated debt, investment asset quality, insurance liability stress, dividends and redeemability. End-2024 debts issued and borrowings were THB10,224 million and consisted of subordinated instruments intended to qualify as Tier 2 capital. Fitch includes USD300 million of regulatory-eligible Tier 2 subordinated debt outstanding in its capital assessment. This strengthens the issuer’s capital, but for subordinated note investors it means ranking, capital features, redemption restrictions and regulatory approval risk that differ from ordinary senior debt. The detailed terms are unconfirmed.

On liquidity, cash and cash equivalents of THB10,631 million and investments in securities of THB569,740 million at end-2024 are the main sources. However, insurer liquidity is driven by claims, maturities, surrenders, reinsurance recoveries, sales of investment assets, derivative collateral and regulatory capital maintenance. Fitch’s negative sensitivities also include an RBC ratio below 280%, deterioration of the Prism score, ROE below 6.5%, and an increase in investment and asset risk. MTL’s credit quality is therefore determined not by the headline CAR alone, but by the balance among capital buffer, insurance underwriting profitability and investment risk.

7. Rating Agency View

Rating agency views are important external validation in MTL’s credit analysis, but ratings should not be used as a substitute for an independent credit view. This is particularly important for insurers because IFS, IDR, National Scale and Tier 2 ratings each indicate different risks. The rating symbol itself is less important than what is being assessed and what constrains the rating.

On 20 February 2025, Fitch affirmed MTL’s IFS at A-, Long-Term IDR at BBB+, National IFS at AAA(tha), and Stable Outlook. Fitch also rates MTL’s USD300 million regulatory-eligible Tier 2 subordinated notes BBB. Fitch’s affirmation reflects MTL’s “Favourable” company profile and “Strong” capital position. For the company profile, Fitch cited an approximately 11% total premium share in the Thai life insurance market, operational support from KBANK and Ageas, a comprehensive product line, customer base and balanced distribution channels.

On capital, Fitch stated that the end-3Q24 Prism Global Model score was Strong and that the RBC ratio improved to 381%. This compares with 353% in 2023 and 332% in 2022, so Fitch viewed regulatory capital as improving. Financial leverage was 9.5% at end-3Q24, down from 14% in 2022. This reflected lower leverage after the repayment of USD100 million of subordinated notes in 2023. Fitch expected the capital position to remain stable in 2025.

Fitch’s key constraint, however, is investment risk. Fitch stated that MTL’s investment portfolio has high risk-asset exposure and expected profitability to continue recovering over the medium term, while investment asset risk remains. For life insurers, investment assets back insurance liabilities, and price fluctuations and credit losses on government bonds, corporate bonds, equities, foreign assets, real estate and affiliates directly affect capital and earnings. Fitch’s view is consistent with this report’s analysis that capital should not be judged solely by the high CAR.

Fitch’s negative sensitivities can be used as practical monitoring indicators. Specifically, rating pressure could arise if the RBC ratio remains below 280% for an extended period, the Prism score deteriorates below Strong, ROE remains below 6.5% for an extended period, or investment and asset risk increases materially. MTL’s current CAR/RBC is well above these thresholds, but caution is needed if capital declines because of investment losses, higher medical claims, product guarantee burdens, rapid surrenders, subordinated debt redemption or changes in dividend policy.

For S&P, the company fact sheet shows BBB+ / Stable as the rating as of 29 October 2024. This report has not obtained the detailed text of S&P’s 2024 report. S&P’s publicly available 2022 update cited MTL’s market position, strategic importance to KBANK, constraints from the Thailand sovereign rating, and domestic concentration of assets as issues. However, that is a previously confirmed view, and the current S&P basis is treated here only as the rating shown in the company fact sheet. This report does not make definitive statements about S&P’s latest detailed rationale.

The National IFS rating of AAA(tha) also requires care. This is the highest insurer financial strength rating on the Thailand domestic scale and does not have the same meaning as an international AAA rating. For international investors, the relevant issuer credit references are Fitch IFS A-, IDR BBB+, Tier 2 BBB, and S&P BBB+. The high domestic-scale rating indicates relative strength versus Thai domestic peers, but it does not mean freedom from the Thailand sovereign, currency, domestic asset concentration or regulatory environment.

8. Credit Positioning

MTL should be positioned as a leading Thai domestic life insurer with strong regulatory capital, investment-grade ratings, and relationships with KBANK and Ageas, while also carrying investment asset risk and insurance liability risk. Its total premium share of 10.51% for January–September 2025 ranked fourth in the industry, and its NBP share of 13.45% ranked third. It is not the overwhelmingly dominant market leader, but it has a sufficiently strong business base as a major insurer.

From a ratings perspective, Fitch IFS A- and S&P BBB+ indicate an investment-grade insurance credit. However, Fitch’s IDR is BBB+ and the Tier 2 rating is BBB, so insurance financial strength, issuer credit and subordinated note risk need to be assessed separately. For domestic investors, the KBANK channel and Ageas involvement may enhance recognition and comfort, but for international investors, constraints remain from the Thailand sovereign, baht interest rates, domestic asset concentration, foreign-currency subordinated debt, insurance regulation and liquidity.

This report does not provide an investment decision on relative value because market price, spread, yield, OAS and comparison with same-maturity bonds have not been confirmed. Based only on public information, MTL’s Tier 2 is investment grade, supported by the issuer’s insurance franchise and high CAR, but it carries subordinated and capital-instrument risk below the issuer IDR. Any buy or hold decision requires separate comparison with Tier 2 instruments of Thai financial institutions, other-country insurer Tier 2 instruments, Thai sovereigns, KBANK-related bonds, and BBB-category insurer subordinated bonds.

In one phrase, MTL’s credit position is that of a major Thai life insurer with a strong business base and regulatory capital, but whose investment assets and insurance liabilities require continued scrutiny. It may be viewed as a stable investment-grade issuer, but that view is a preliminary assessment that relies on Fitch’s view, the company’s CAR and the partial investment asset breakdown that has been confirmed. For subordinated notes, pricing must reflect subordination to policyholders, regulatory capital features, investment asset stress and Thailand domestic risk.

9. Key Credit Strengths and Constraints

The credit strengths are MTL’s leading franchise in the Thai life insurance market, bancassurance agreement with KBANK, Ageas’s insurance expertise, high regulatory capital buffer and investment-grade ratings. The company’s second-place NBP ranking in 2024, total premium share of 11.0%, Q3 2025 CAR of 499%, and Fitch’s Strong capital assessment indicate that it is not a marginal insurer and has a degree of loss-absorption capacity and market access. However, KBANK and Ageas support is ordinary-course business support, not a debt guarantee.

The main constraints are investment asset risk, opacity around insurance liabilities and ALM, increases in claims and benefits, and the ranking of Tier 2 subordinated notes. Investment assets are fixed-income oriented, but also include equities and unit trusts, while FX, duration and concentration risks are unconfirmed. On the insurance liability side, 2024 net benefit payments and insurance claims increased materially, and insurance underwriting profitability cannot be described as strong without confirming guaranteed rates, liability duration, surrender rates, claims ratios and reinsurance protection. Tier 2 subordinated notes rank below policyholder liabilities and senior debt, and Fitch rates them BBB, below the IDR. They should therefore be assessed separately from the issuer’s insurance financial strength.

10. Downside Scenarios and Monitoring Triggers

MTL’s realistic downside scenarios can be divided into four broad categories. The first is investment asset stress. If sudden changes in Thai government bond yields, equity market declines, valuation losses on low-rated bonds, foreign bonds, real estate or affiliate investments, and credit spread widening occur at the same time, investment income, other comprehensive income, regulatory capital and RBC could deteriorate. Given Fitch’s identification of investment risk as a constraint, the rating and asset-class breakdown of the investment portfolio is the most important monitoring item.

The second is insurance liability and ALM stress. If low interest rates persist, reinvestment yields may be insufficient relative to guaranteed rates on past products, compressing long-term spread earnings. If interest rates rise sharply, bond valuation losses, higher surrenders, and collateral or liquidity burdens may become issues. If the mismatch between asset duration and liability duration is large, interest-rate movements can affect accounting, economic value and regulatory capital. The ALM gap has not been confirmed in this report and should be a priority item in the next update.

The third is medical and protection claims stress. Expansion of health and critical illness products fits customer demand, but exposes the company to medical inflation, hospital networks, utilisation frequency, treatment costs and rising claims. If repricing is delayed, reinsurance protection is weak, or price adjustment on the in-force book is difficult, insurance underwriting profit could be pressured. Health insurance in particular can create tension between brand / customer satisfaction and repricing. It is therefore necessary to examine not only product sales growth but also claims ratios, reinsurance, repricing and the impact of copayment introductions.

The fourth is disruption in sales and renewal premium. RYP declined 5.1% year on year in 2024, and the company explained this as reflecting paid-up policies. If the decline in renewal premium is not temporary and reflects maturities, surrenders, competition, sales quality or reduced product appeal, earnings stability would weaken. Total premium share for January–September 2025 was also 10.51%, slightly below the full-year 2024 level of 11.0%. The company maintains a major-market position, but RYP, persistency rates, surrender rates and total premium share should be monitored continuously.

Additional downside factors include changes in shareholder and channel relationships. The bancassurance agreement with KBANK is an important distribution base, and contract terms, fees, sales policy and strategic changes on the bank side can affect MTL’s new business. Ageas’s involvement also supports expertise, but if the shareholder structure or strategy changes, the impact on governance, products and capital policy needs to be examined.

On ratings and capital, Fitch’s sensitivities can be used as practical monitoring triggers. If RBC remains below 280% for an extended period, the Prism score falls below Strong, ROE stays below 6.5% for a prolonged period, or investment asset risk rises materially, rating pressure could increase. There is currently distance from these thresholds given the company fact sheet CAR of 499%, but the speed of decline should be watched if investment losses and higher claims occur simultaneously.

11. Credit View and Monitoring Focus

At present, MTL can be assessed as an investment-grade insurer with a leading franchise in the Thai life insurance market and a high regulatory capital ratio. However, the basis for viewing it as “stable” mainly relies on the company’s CAR, Fitch’s Strong capital assessment, its leading market position and the partial breakdown of investment assets that has been confirmed. Because foreign currency exposure and duration of investment assets, guaranteed rates and ALM of insurance liabilities, health claims, reinsurance and individual terms of the Tier 2 subordinated notes are not sufficiently visible, this report’s credit view is a conservative initial assessment. The speed of change could become faster in a situation where investment-market stress and higher claims overlap.

The largest factors supporting MTL’s credit quality are its leading insurance franchise, business support including KBANK and Ageas, premium scale, high CAR/RBC and investment-grade ratings. Its market position as the second-ranked NBP writer in 2024 and fourth-ranked total-premium writer for January–September 2025 indicates that the company is not a marginal issuer in the Thai life insurance market. The company fact sheet CAR of 499% and Fitch’s Strong capital assessment also support current loss-absorption capacity. However, the Tier 2 capital recognition effect and investment asset risk need to be taken into account. The KBANK channel and Ageas involvement support distribution, expertise and governance, but they are not debt guarantees.

Conversely, the constraints on MTL’s assessment are the size of its investment assets and insurance liabilities. At end-2024, investments in securities were approximately THB569.7 billion and life insurance reserves and insurance premium reserves were approximately THB524.1 billion, so the company’s credit quality depends heavily on the quality of assets and liabilities. Investment assets are fixed-income oriented, with large credit-risk-free and above-BBB bond holdings, but equities of THB76.1 billion and bonds rated BBB and below of THB26.4 billion are also confirmed. The high CAR alone should not be used to understate credit risk.

For Tier 2 subordinated note investors, issuer credit and security risk need to be separated. The IFS rating of A- indicates insurance financial strength, but the IDR is BBB+ and the Tier 2 rating is BBB. The subordinated notes rank below policyholder liabilities and senior debt, and have capital features as regulatory capital. Therefore, MTL’s Tier 2 has a degree of credit strength backed by the issuer’s business base, but it cannot be valued in the same way as senior debt. Before any individual investment, it is necessary to confirm how coupon deferral, write-down, conversion, regulatory call, OIC approval, tax / FX hedging and capital recognition through the 2037 maturity are defined in the bond documentation.

The first monitoring focus is the full-year 2025 annual report, Q4 2025 fact sheet or 2025 audited financial statements. As of Q3 2025, total premium, market share, CAR and total assets can be confirmed, but net profit, insurance liabilities, claims ratios, reinsurance and ALM remain insufficient. The second focus is the quality of the investment portfolio. In addition to the ratios of government and state-enterprise bonds, debentures / deposits / notes, equities and unit trusts, FX, duration, ratings and concentrations need to be confirmed. The third focus is claims and repricing for protection and health products. Health products provide a growth opportunity, but medical inflation and claims can pressure credit quality. The fourth focus is the KBANK channel and RYP. In addition to new business, renewal premium, persistency, surrender rates and paid-up policy trends should be monitored.

At present, it is reasonable to continue monitoring MTL as a major Thai life insurer with a high regulatory capital ratio. However, this report does not provide a relative-value judgment. Market spreads, similarly rated insurer subordinated notes, Thai financial institution Tier 2 instruments, Thai sovereigns, KBANK-related bonds and individual Tier 2 terms have not been confirmed. If a fund manager is making an investment decision, this issuer credit analysis should be used as a base, with additional checks on price, terms, liquidity, redeemability, regulatory approval, tax and hedging.

12. Short Summary & Conclusion

Muang Thai Life Assurance is a major life insurer with a leading premium share in the Thai life insurance market, supported by its bancassurance relationship with KBANK and Ageas’s insurance expertise. Its credit quality is supported by high CAR/RBC and investment-grade ratings, but investment asset risk, insurance liabilities and ALM, claims and benefits, renewal premium, and the ranking differential of the USD Tier 2 subordinated notes need to be separated. The issuer appears stable, but that assessment is an initial view based on Fitch’s assessment and company disclosures. For subordinated debt investment, it is essential to assess not only issuer credit, but also regulatory capital features, interest-payment and redemption restrictions, and the specific bond terms.

13. Sources

Primary Sources

• Muang Thai Life Assurance Public Company Limited, Annual Report 2024, accessed 2026-05-13.
  https://www.muangthai.co.th/reports/annual-report-2024/index.html
• Muang Thai Life Assurance Public Company Limited, IR Fact Sheet Vol.98 (Q3/2025), published 2025-11-25, accessed 2026-05-13.
  https://www.muangthai.co.th/assets/6f0efd20-5a3d-4020-8bc4-4f222f64fd2d/20251125%20IR%20Fact%20Sheet_Vol.98_Q3-25_EN.pdf
• Muang Thai Life Assurance Public Company Limited, Investor Relations page, accessed 2026-05-13.
  https://www.muangthai.co.th/en/about-mtl/investor-relations
• Muang Thai Life Assurance Public Company Limited, Go Healthier with MTL campaign page, accessed 2026-05-13.
  https://www.muangthai.co.th/en/campaign/gohealthier
• Kasikornbank PCL, 4Q24 Investor Presentation (updated economic data), accessed 2026-05-13.
  https://www.kasikornbank.com/en/IR/PresentationJournal/webcast/KBank_Investor_Presentation_4Q24%20%28Updated%20Econ%20Data%29.pdf

Rating Agency Sources

• Fitch Ratings, Fitch Affirms Muang Thai Life's IFS Rating at 'A-'; Outlook Stable, 2025-02-20, accessed 2026-05-13.
  https://www.fitchratings.com/research/insurance/fitch-affirms-muang-thai-life-ifs-rating-at-a-outlook-stable-20-02-2025
• S&P Global Ratings, Research Update: Muang Thai Life Assurance 'BBB+' Rating Affirmed; Outlook Stable, 2022-10-31, accessed 2026-05-13.
  https://www.spglobal.com/ratings/en/regulatory/article/-/view/sourceId/12546238

Internal Working Data

• issuer_summary/issuers/muang_thai_life/data/muang_thai_life_key_metrics_20260513.json
• issuer_summary/issuers/muang_thai_life/working/muang_thai_life_20260513_writing_plan.md

Unverified / Pending

• The full-year 2025 Annual Report, Q4 2025 Fact Sheet, or 2025 audited financial statements had not been obtained as of the report date.
• The detailed text of S&P Global Ratings’ 29 October 2024 update has not been obtained. Only the rating shown in the company fact sheet has been confirmed.
• The offering circular, trust deed, coupon deferral, write-down, conversion, regulatory call and OIC approval conditions for the USD Tier 2 subordinated notes are unconfirmed.
• Investment assets have been partially confirmed from the annual report notes and KBANK materials, but details by currency, duration, issuer concentration, liquidity haircut, and low-rated bond, equity, real estate and affiliate investment exposures are unconfirmed.
• Asset and liability duration, guaranteed rates, ALM gap, surrender rates, persistency rates, claims ratios, scope for repricing health insurance, and reinsurance programme are unconfirmed.
• Market price, spread, yield, OAS and relative value versus peer and similarly rated bonds are unconfirmed.